Skip to main contentU.S. National Library of MedicineU.S. National Library of Medicine

Profiles in Science
Pinterest badge Follow Profiles in Science on Pinterest!

The Francis Crick Papers

Letter from Francis Crick to Sewell Champe pdf (158,643 Bytes) transcript of pdf
Letter from Francis Crick to Sewell Champe
Crick here responded to Champe's report of results from his research with the rII mutants of the bacterial viruses T2 (phage) which had been used since the early 1950s in genetic mapping experiments. Crick himself discussed results of research with acridine mutants of bacteriophage T2, a different family of mutants in whose study Crick's laboratory specialized and which he used to provide evidence for the three-letter composition of the genetic code. The specific experiments to which Crick referred were with acridine mutants called amber (the triplet UAA) and ochre (UAG) and with the triplet UGA, all three of which signal the end of the polypeptide chain in protein synthesis.
Number of Image Pages:
2 (158,643 Bytes)
1967-03-06 (March 6, 1967)
Crick, Francis
Champe, Sewell
Original Repository: Wellcome Library for the History and Understanding of Medicine. Francis Harry Compton Crick Papers
   Disclaimer; please review our Privacy Policy
Reproduced with permission of the Wellcome Library for the History and Understanding of Medicine.
   Disclaimer; please review our Privacy Policy
Medical Subject Headings (MeSH):
Genetic Code
Exhibit Category:
Embryology and the Organization of DNA in Higher Organisms, 1966-1976
Metadata Record Letter from Sewell Champe to Francis Crick (March 1, 1967) pdf (152,502 Bytes) transcript of pdf
Box Number: 8
Folder Number: PP/CRI/D/1/1/3
Unique Identifier:
Document Type:
Letters (correspondence)
Physical Condition:
Series: Correspondence
SubSeries: Alphabetical Correspondence
SubSubSeries: Correspondence 1
Folder: Correspondence C
6th March 1967.
Dear Sewell,
We were very pleased to get your letter, and learn the new information about the position of component 30. It certainly seems that you do not pick this up unless the gene is working fairly strongly. We assume from what you say about the expected size of the peptide that you have located the right-hand end of it, presumably by using amber mutants. Sydney is very keen that you should try the effect of a UGA mutant to the right of component 30. We now have a weak suppressor for UGA and so we can always obtain it wherever we have an ochre. It would be interesting to compare the effect of an ochre and UGA at the same site to the right of component 30. If you will let us know roughly where component 30 is Sydney would be very pleased to produce such a pair of mutants for you (we would probably also make the amber as well if we could). Of course, we would expect that with an ochre or an amber there you should find a reasonable amount of component 30, but we are not at all clear what to expect for UGA.
As far as I recall the evidence of last summer about the revertants of ochres turned out to be no good because when Sydney looked into Anand's data the reversion rate was far too small to be significant.
Both Sydney and I would welcome William McClain in either the summer or fall of 1968 (it would not be possible to have him earlier), so do encourage him to look into fellowships. I am asking Leslie Barnett to send you the mutants you ask for. Sydney is very curious to know why you would like some of them!
F.H.C. Crick.
Metadata Last Modified Date:
Linked Data:
RDF/XML     JSON     JSON-LD     N3/Turtle     N-Triples